Trusted News Discovery Since 2008
{{/content}}
55% Covidshield recipients had mild side effects: AMCH study
Credit: IndiaTimes- Published 2 weeks ago
You are here
💡 newsR Knowledge: Other News Mentions
Oxford–AstraZeneca COVID-19 vaccine
Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
Credit: IndiaTimes - Published 2 days ago